Search Prime Contracts

75N93019C00050

Definitive Contract

Overview

Government Description
This contract will support component a of the collaborative influenza vaccine innovation centers (CIVICS) program to design and evaluate innovative influenza vaccine approaches, based on principles of influenza immunity, that achieve durable, robust immunity. Includes the design and selection of hemagglutinin-based immunogens, biochemical and structural characterization of antibodies from animal models, and optimization of immunogen mrna for peak translation and immunogenicity. Additional tasks involve developing and testing mrna vaccines expressing multiple influenza antigens in animal models, establishing pipelines for epitope mapping and immune-response evaluation, and performing next-generation sequencing and proteomic analysis of b-cell and serological antibody repertoires. The overall effort aims to advance universal and improved influenza vaccines through structure-based and platform development approaches, including evaluation in preclinical and early phase clinical studies.
Place of Performance
Durham, NC 27705 United States
Pricing
Cost No Fee
Set Aside
None
Extent Competed
Full And Open Competition
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 09/09/20 to 09/09/26 and the Potential Award value has increased 7% from $107,096,778 to $115,008,948.
Subcontracting Plan This Definitive Contract has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Duke University was awarded Definitive Contract 75N93019C00050 (75N930-19-C-00050) for Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A Support worth up to $115,008,948 by the National Institute of Allergy and Infectious Diseases in September 2019. The contract has a duration of 7 years and was awarded through solicitation 2018 NIAID Omnibus Broad Agency Announcement full & open with NAICS 541715 and PSC AN12 via direct negotiation acquisition procedures with 9 bids received. As of today, the Definitive Contract has a total reported backlog of $48,465,336.

Status
(Open)

Last Modified 7/1/25
Period of Performance
9/10/19
Start Date
9/9/26
Current End Date
9/9/26
Potential End Date
97.0% Complete

Obligations and Backlog
$66.5M
Total Obligated
$66.5M
Current Award
$115.0M
Potential Award
58% Funded
$0.0
Funded Backlog
$48.5M
Total Backlog

Award Hierarchy

Definitive Contract

75N93019C00050

Subcontracts

-

Activity Timeline

Interactive chart of timeline of amendments to 75N93019C00050

Labor Services Billing

Annual labor billing rates and FTE reported for 75N93019C00050

Subcontract Awards

Disclosed subcontracts for 75N93019C00050

Opportunity Lifecycle

Procurement history for 75N93019C00050

Transaction History

Modifications to 75N93019C00050

People

Suggested agency contacts for 75N93019C00050

Competition

Number of Bidders
9
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Yes
Business Size Determination
Large Business
Awardee UEI
TP7EK8DZV6N5
Awardee CAGE
4B478
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhsgdurham
Last Modified By
hhsalewis
Approved By
hhsalewis

Legislative

Legislative Mandates
None Applicable
Performance District
NC-04
Senators
Thom Tillis
Ted Budd
Representative
Valerie Foushee

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services (075-0885) Health research and training Research and development contracts (25.5) $36,720,592 95%
Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) Health care services Research and development contracts (25.5) $1,376,151 4%
Modified: 7/1/25